David R. McAvoy
General Counsel, ENDOCYTE INC.
Companies
- Teva Pharmaceutical Industries Ltd.General counsel Mar 5, 2024 to now1
- Fresh Tracks Therapeutics, Inc.Gen Counsel, CCO, & Secretary Jan 26, 2023 to Oct 4, 20232
- Fresh Tracks Therapeutics, Inc.General counsel Sep 9, 2019 to May 9, 20223
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Teva Pharmaceutical Industries Ltd. TEVA13,027 shares4$539.5K at $41.41Sep 5, 2025- Fresh Tracks Therapeutics, Inc.16,371 shares5Oct 4, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 5, 2025Bought 1,113 shares at $18.86 of Teva Pharmaceutical Industries Ltd.4
- Mar 5, 2025Sold 1,677 shares at $15.91 of Teva Pharmaceutical Industries Ltd.6
- Mar 4, 2025Sold 3,150 shares at $15.73 of Teva Pharmaceutical Industries Ltd.6
- Mar 4, 2025Exercised options 16,741 shares of Teva Pharmaceutical Industries Ltd.6
- Oct 2, 2023Shares withheld for tax 7,358 shares at $0.98 of Fresh Tracks Therapeutics, Inc.5
- Oct 2, 2023Exercised options 20,000 shares of Fresh Tracks Therapeutics, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Mar 6, 2025